© 2020 MJH Life Sciences and HCPLive. All rights reserved.
July 23, 2020
The Patient Controller will join a growing list of Abbott digital care products aimed at streamlining the therapeutic experience.
April 27, 2020
The new approval is based on the result of 38 clinical trials involving more than 1000 patients.
April 16, 2020
Impulse control disorder symptoms also commonly found in Parkinson disease patients treated with dopamine agonists.
March 21, 2020
Study data suggested that up to 80% of patients with Parkinson disease may have ophthalmologic symptoms.
February 21, 2020
New drug more often linked to a full ON response from Parkinson disease patients at 30 minutes when compared to a placebo.
February 14, 2020
Patients in the treatment group had improved dyskinesia symptoms and off time.
February 11, 2020
A multifaceted care plan for patients is shown to improve both their quality of life and the burden of treatment for caregivers.
January 30, 2020
Investigators will move forward with a phase 2 study testing AV-101 as a potential treatment for patients with Parkinson disease receiving levodopa-based therapy.
January 24, 2020
The approval expands options for patients with Parkinson disease to tailor treatment to their unique needs.
January 16, 2020
Of the 176 adverse events found in a trial targeting ambroxol as a Parkinson disease drug, only 3 were deemed related to the treatment.